ADPT
Adaptive Biotechnologies Corporation (ADPT)
$39
About Adaptive Biotechnologies Corporation (ADPT)
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Details
Daily high
$6.50
Daily low
$5.84
Price at open
$5.84
52 Week High
$7.07
52 Week Low
$2.28
Market cap
943.0M
Dividend yield
0.00%
Volume
1.6M
Avg. volume
1.4M
P/E ratio
-4.78
Adaptive Biotechnologies Corporation News
Details
Daily high
$6.50
Daily low
$5.84
Price at open
$5.84
52 Week High
$7.07
52 Week Low
$2.28
Market cap
943.0M
Dividend yield
0.00%
Volume
1.6M
Avg. volume
1.4M
P/E ratio
-4.78